Pregnancy in active acromegaly;Schwangerschaft während aktiver akromegalie

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 45, 2008, Pages 2328-2331

  Sahli, Rahel ^a   Christ, E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Complications; Pregnancy in acromegaly; Therapeutic options

Indexed keywords

GLUCOSE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AMENORRHEA AND OLIGOMENORRHEA; ARTICLE; CASE REPORT; FEMALE; HEMIANOPIA; HUMAN; HYPOPHYSIS ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; ADENOMA; CHEMOLUMINESCENCE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE SECRETING ADENOMA; MULTIMODALITY CANCER THERAPY; OLIGOMENORRHEA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME;

ACROMEGALY; ADENOMA; ADULT; CHEMILUMINESCENT MEASUREMENTS; COMBINED MODALITY THERAPY; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; OLIGOMENORRHEA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 55249086116     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1100923     Document Type: Article

References (16)

1. Alsat AE, Guibourdenche J, Luton D, Frankenne F, Evain-Brion D. Human placental growth hormone. Am J Obstet Gynecol 1997; 177 (6): 1526-1534
2. Atmaca A, Dagdelen S, Erbas T. Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 2006; 114 (3): 135-139
3. Beckers A, Stevenaert A, Foidart JM, Hennen G, Frankenne F. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 1990; 71 (3): 725-731
4. Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 2007; 92 (9): 3374-3377
5. Cozzi R, Attanasio R, Barausse M. Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 2006; 155 (2): 279-284
6. Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B. Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol (Oxf) 2001; 55 (3): 411-415
7. Fholenhag KI, Sandstrom IM, Malmlof K, Skottner AI, Nyberg FJ. Human growth hormone does not cross the placenta of the pregnant rat. Growth Regul 1994; 4 (4): 181-187
8. Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85 (2): 217-220
9. Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 1998; 83 (3): 727-731
10. Hills FA, English J, Chard T. Circulating levels of IGF-1 and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996; 148 (2): 303-309
11. Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 1994; 121 (7): 473-477
12. Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev 2004; 25 (5): 693-721
13. Magyar DM, Marshall JR. Pituitary tumors and pregnancy. Am J Obstet Gynecol 1978; 132 (7): 739-751
14. Melmed S. Medical Progress: Acromegaly. N Engl J Med 2006; 355 (24): 2558-2573
15. Molitch ME. Pituitary diseases in pregnancy. Semin Perinatol 1998; 22 (6): 457-470
16. Yap AS, Clouston WM, Mortimer RH, Drake RF. Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy. Am J Obstet Gynecol 1990; 163 (2): 477-478